Adeno-associated virus vectors integrate at chromosome breakage sites
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Adeno-associated virus (AAV) vectors transduce cells by multiple pathways, including integration at nonhomologous chromosomal locations by an unknown mechanism. We reasoned that spontaneous chromosome breaks may facilitate vector integration and investigated this in cells containing a specific chromosomal double-strand break created by the endonuclease I-SceI or multiple breaks created by treatment with etoposide or gamma-irradiation. Vector proviruses were found at I-SceI cleavage sites, and sequencing of vector-chromosome junctions detected microhomologies, deletions and insertions that were similar when integration occurred spontaneously at random locations or at induced double-strand breaks. Infection with AAV vectors did not increase mutation rates in normal human cells. Our results establish a mechanism for integration and suggest that AAV vectors can integrate at existing chromosome breaks rather than causing breaks themselves, which has implications for their clinical use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Integration events can be increased by increasing dsDNA breaks in vitro by adding intron-encoded endonuclease I-SceI, etoposide, or γ-irradiation [244].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [244]
Citations
Cites
Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses
Rothkamm, K., & Löbrich, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830918100 · Cited by 1,645
Zolotukhin, S., Byrne, B. J., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R. J., & Muzyczka, N. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300938 · Cited by 1,312
Rouet, P., Smih, F., & Jasin, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.8096 · Cited by 791
Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors
Grimm, D., Kern, A., Rittner, K., & Kleinschmidt, J. A. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.18-2745 · Cited by 696
Homology-directed repair is a major double-strand break repair pathway in mammalian cells
Liang, F., Han, M., Romanienko, P. J., & Jasin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5172 · Cited by 649 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundQuantitative Detection of125IdU-Induced DNA Double-Strand Breaks with γ-H2AX Antibody
Sedelnikova, O. A., Rogakou, E. P., Panyutin, I. G., & Bonner, W. M. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0486:qdoiid]2.0.co;2 · Cited by 611 · cited 1×
“These low values are consistent with the expected toxicity of DSBs and with earlier estimates based on staining for γ-H2A”
ResultFrequent chromosomal translocations induced by DNA double-strand breaks
Richardson, C., & Jasin, M. (2000) · Nature · doi:10.1038/35015097 · Cited by 517 · cited 1×
“, as these can also occur when DSBs undergo normal cellular repair processe”
BackgroundMechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme
Burden, D. A., & Osheroff, N. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00132-8 · Cited by 503
Yee, J. K., Miyanohara, A., LaPorte, P., Bouic, K., Burns, J. C., & Friedmann, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9564 · Cited by 487
Single-strand interruptions in replicating chromosomes cause double-strand breaks
Kuzminov, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131009198 · Cited by 406
Cited by
Items 101–200 of 266
Hemophilia B and gene therapy: a new chapter with etranacogene dezaparvovec
Anguela, X. M., & High, K. A. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023010511 · Cited by 53
van Rensburg, R., Beyer, I., Yao, X. Y., Wang, H., Denisenko, O. N., Li, Z. Y., Russell, D. W., Miller, D. G., Gregory, P. D., Holmes, M. C., et al. (2012) · Gene Therapy · doi:10.1038/gt.2012.25 · Cited by 55
Self-citationvan Hees, M., Slott, S., Hansen, A. H., Kim, H. S., Ji, H. P., & Astakhova, K. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.06.003 · Cited by 47
Hemophilia Gene Therapy: The End of the Beginning?
Wolf, D. D., Singh, K., Chuah, M., & VandenDriessche, T. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.112 · Cited by 50
Petek, L. M., Fleckman, P. H., & Miller, D. G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.102 · Cited by 51
Self-citationStructural and cellular biology of adeno-associated virus attachment and entry
Zengel, J. R., & Carette, J. E. (2020) · Advances in virus research · doi:10.1016/bs.aivir.2020.01.002 · Cited by 54
Ocular delivery of CRISPR/Cas genome editing components for treatment of eye diseases
Yu, W., & Wu, Z. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.011 · Cited by 50
High-Throughput Sequencing Reveals Principles of Adeno-Associated Virus Serotype 2 Integration
Janovitz, T., Klein, I. A., Oliveira, T. Y., Mukherjee, P., Nussenzweig, M. C., Sadelain, M., & Falck-Pedersen, E. (2013) · Journal of Virology · doi:10.1128/jvi.01135-13 · Cited by 47
AAV vectors and tumorigenicity
Kay, M. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1111 · Cited by 50
Romano, G. (2012) · ISRN Oncology · doi:10.5402/2012/616310 · Cited by 41
Site-directed genome modification: derivatives of DNA-modifying enzymes as targeting tools
Coates, C. J., Kaminski, J., Summers, J. B., Segal, D. J., Miller, A. D., & Kolb, A. F. (2005) · Trends in biotechnology · doi:10.1016/j.tibtech.2005.06.009 · Cited by 43
CRISPR/Cas9: at the cutting edge of hepatology
Pankowicz, F. P., Jarrett, K. E., Lagor, W. R., & Bissig, K. (2017) · Gut · doi:10.1136/gutjnl-2016-313565 · Cited by 46
Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease
Brommel, C. M., Cooney, A. L., & Sinn, P. L. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.138 · Cited by 45
He, X., Zhang, Z., Xue, J., Wang, Y., Zhang, S., Wei, J., Zhang, C., Wang, J., Urip, B. A., Ngan, C. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34898-y · Cited by 43
Emerging Strategies for the Treatment of Hereditary Metabolic Storage Disorders
Brady, R. O. (2006) · Rejuvenation Research · doi:10.1089/rej.2006.9.237 · Cited by 40
Bloomer, H., Smith, R. H., Hakami, W., & Larochelle, A. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.010 · Cited by 44
Gellhaus, K., Cornu, T. I., Heilbronn, R., & Cathomen, T. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.167 · Cited by 40
New insights into stability of recombinant adenovirus vector genomes in mammalian cells
Rauschhuber, C., Noske, N., & Ehrhardt, A. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.01.006 · Cited by 45
Targeted Gene Delivery: Where to Land
Pavani, G., & Amendola, M. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.609650 · Cited by 55
Han, Z., Zhong, L., Maina, N., Hu, Z., Li, X., Chouthai, N. S., Bischof, D., Weigel-Van Aken, K. A., Slayton, W. B., Yoder, M. C., et al. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.161 · Cited by 35
Cataldi, M. P., & McCarty, D. M. (2010) · Journal of Virology · doi:10.1128/jvi.00641-10 · Cited by 35
Martins, K. M., Breton, C. A., Zheng, Q., Zhang, Z., Latshaw, C., Greig, J. A., & Wilson, J. M. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.134 · Cited by 38
Tasca, F., Wang, Q., & Gonçalves, M. A. F. V. (2020) · Cells · doi:10.3390/cells9040953 · Cited by 37
Kabra, M., Shahi, P. K., Wang, Y., Sinha, D., Spillane, A., Newby, G. A., Saxena, S., Tong, Y., Chang, Y., Abdeen, A. A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci171356 · Cited by 48
Saunders, A. B., & Sabatini, B. L. (2015) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0124s72 · Cited by 36
Cell and Gene Therapy for Friedreich Ataxia: Progress to Date
Evans‐Galea, M. V., Pébay, A., Dottori, M., Corben, L. A., Ong, S. H., Lockhart, P. J., & Delatycki, M. B. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.180 · Cited by 41
Genome Engineering with TALE and CRISPR Systems in Neuroscience
Lee, H. B., Sundberg, B. N., Sigafoos, A. N., & Clark, K. J. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00047 · Cited by 41
Brescia, M., Janssen, J. M., Liu, J., & Gonçalves, M. A. F. V. (2020) · Cells · doi:10.3390/cells9040869 · Cited by 31
DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition
Koyama, T., Sun, B., Tokunaga, K., Tatsumi, M., & Ishizaka, Y. (2013) · Retrovirology · doi:10.1186/1742-4690-10-21 · Cited by 38
Therapeutic strategies for autism: targeting three levels of the central dogma of molecular biology
Hong, D., & Iakoucheva, L. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02356-y · Cited by 36
Retson, L., Tiwari, N. R., Vaughn, J. A., Bernes, S. M., Adelson, P. D., Mansfield, K. G., Libertini, S., Kuzmiski, J. B., Alecu, I., Gabriel, R., et al. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.08.013 · Cited by 29
Strategies to improve safety profile of AAV vectors
Suoranta, T., Laham-Karam, N., & Ylä‐Herttuala, S. (2022) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2022.1054069 · Cited by 33
Gene Therapy to Improve Pancreatic Islet Transplantation for Type 1 Diabetes Mellitus
Hughes, A., Jessup, C. F., Drogemuller, C., Mohanasundaram, D., Milner, C. R., Rojas, D., Russ, G. R., & Coates, P. T. H. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793360897 · Cited by 31
Blasi, M., Negri, D., LaBranche, C., Alam, S. M., Baker, E. J., Brunner, E. C., Gladden, M. A., Michelini, Z., Vandergrift, N. A., Wiehe, K. J., et al. (2018) · Communications Biology · doi:10.1038/s42003-018-0131-6 · Cited by 27
A primer to gene therapy: Progress, prospects, and problems
Zittersteijn, H. A., Gonçalves, M. A. F. V., & Hoeben, R. C. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12270 · Cited by 30
Yin, J., Fang, K., Gao, Y., Ou, L., Yuan, S., Xin, C., Wu, W., Wu, W., Hong, J., Yang, H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35640-4 · Cited by 32
Weltner, J., Anisimov, A., Alitalo, K. K., Otonkoski, T., & Trokovic, R. (2012) · Journal of Virology · doi:10.1128/jvi.06302-11 · Cited by 30
Intégration des vecteurs AAV et mutagenèse insertionnelle
Rossi, A., & Salvetti, A. (2016) · médecine/sciences · doi:10.1051/medsci/20163202010 · Cited by 31
Chen, X., Niu, X., Liu, Y., Zheng, R., Yang, L., Lu, J., Yin, S., Wei, Y., Pan, J., Sayed, A. M. M., et al. (2022) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2022.06.001 · Cited by 25
AAV-Based Gene Therapy: Opportunities, Risks, and Scale-Up Strategies
Moldavskii, D., Gilazieva, Z., Fattakhova, А. N., Solovyeva, V. V., Issa, S. S., Sufianov, A. A., Суфианова, Г. З., & Rizvanov, A. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178282 · Cited by 28
Allen, D. G., Knop, O., Itkowitz, B., Kalter, N., Rosenberg, M., Iancu, O., Beider, K., Lee, Y. N., Nagler, A., Somech, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42036-5 · Cited by 28
Meng, X., Jia, R., Zhao, X., Zhang, F., Chen, S., Yu, S., Liu, X., Dou, H., Feng, X., Zhang, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48092-9 · Cited by 33
Gonçalves, M. A. F. V., Holkers, M., van Nierop, G. P., Wieringa, R., Pau, M. G., & de Vries, A. A. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003084 · Cited by 25
Oziolor, E. M., Kumpf, S. W., Qian, J., Gosink, M. M., Sheehan, M. J., Rubitski, D. M., Newman, L., Whiteley, L. O., & Lanz, T. A. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.04.009 · Cited by 23
Strategies for enhanced gene delivery to the central nervous system
Gao, Z. (2024) · Nanoscale Advances · doi:10.1039/d3na01125a · Cited by 29
Lindel, F., Dodt, C., Weidner, N., Noll, M., Bergemann, F., Behrendt, R., Fischer, S., Dietrich, J., Cartellieri, M., Hamann, M. V., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.006 · Cited by 22
Drew, H. R., Lockett, L. J., & Both, G. W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82880-0 · Cited by 25
Zinc finger nucleases: Tailor-made for gene therapy
Chou, S., Leng, Q., & Mixson, A. J. (2012) · Drugs of the Future · doi:10.1358/dof.2012.037.03.1779022 · Cited by 43
Bazick, H., Mao, H., Niehaus, J. K., Wolter, J. M., & Zylka, M. J. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.032 · Cited by 20
Applications of multiplexed CRISPR–Cas for genome engineering
Cheng, H., Jeong, E., & Cho, S. W. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01500-6 · Cited by 30
Genome Engineering Using Adeno-Associated Virus (AAV)
Howes, R., & Schofield, C. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1862-1_5 · Cited by 18
Kojima, S., Yoshikawa, K., Ito, J., Nakagawa, S., Parrish, N. F., Horie, M., Kawano, S., & Tomonaga, K. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010758118 · Cited by 18
Zhong, J., Gou, Y., Zhao, P., Dong, X., Guo, M., Li, A., Hao, A., Luu, H. H., He, T., Reid, R. R., et al. (2023) · Pediatric Discovery · doi:10.1002/pdi3.3 · Cited by 18
Singh, K., Fronza, R., Evens, H., Chuah, M., & VandenDriessche, T. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101365 · Cited by 19
Integration and the risk of liver cancer—Is there a real risk?
Kasimsetty, A., & Sabatino, D. E. (2024) · Journal of Viral Hepatitis · doi:10.1111/jvh.13915 · Cited by 21
Genetically Engineering the Nervous System with CRISPR-Cas
Sandoval, A., Elahi, H., & Ploski, J. E. (2020) · eNeuro · doi:10.1523/eneuro.0419-19.2020 · Cited by 19
Genetic therapies for neurological disorders
FitzPatrick, L., & Bird, A. P. (2021) · Human Genetics · doi:10.1007/s00439-021-02399-5 · Cited by 21
The effects of polymorphisms on human gene targeting
Deyle, D. R., Li, L. B., Ren, G., & Russell, D. W. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1303 · Cited by 18
Self-citationInteraction of vectors and parental viruses with the host genome
Gil-Fariña, I., & Schmidt, M. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.07.004 · Cited by 19
Simple Monitoring of Gene Targeting Efficiency in Human Somatic Cell Lines Using the PIGA Gene
Karnan, S., Konishi, Y., Ota, A., Takahashi, M., Damdindorj, L., Hosokawa, Y., & Konishi, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047389 · Cited by 16
De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications
Katona, R. L. (2015) · Chromosome Research · doi:10.1007/s10577-014-9458-0 · Cited by 17
Nuclease-free Adeno-Associated Virus-Mediated Il2rg Gene Editing in X-SCID Mice
Hiramoto, T., Li, L. B., Funk, S. E., Hirata, R. K., & Russell, D. W. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.028 · Cited by 16
Self-citationLarge-scale molecular epidemiological analysis of AAV in a cancer patient population
Qin, W., Xu, G., Tai, P. W. L., Wang, C., Luo, L., Li, C., Hu, X., Xue, J., Lü, Y., Zhou, Q., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01725-5 · Cited by 15
Wu, X., Blackburn, P. R., Tschumper, R. C., Ekker, S. C., & Jelinek, D. F. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.32 · Cited by 16
Gene therapy for hemophilia, a clinical viewpoint
Chou, S., Hsu, Y., & Lin, S. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.008 · Cited by 16
Balaggan, K. S., Durán, Y., Georgiadis, A., Thaung, C., Barker, S. E., Buch, P. K., MacNeil, A., Robbie, S. J., Bainbridge, J. W., Smith, A. J., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.194 · Cited by 18
Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing
Moyo, B., Brown, L. B. C., Khondaker, I., & Bao, G. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123314 · Cited by 13
Evans, J. M., Navarro, S., Doki, T., Stewart, J. M., Mitsuhashi, N., & Kearns‐Jonker, M. (2012) · Journal of Transplantation · doi:10.1155/2012/740653 · Cited by 13
Parp3 promotes long-range end joining in murine cells
Layer, J. V., Cleary, J. P., Brown, A. J., Stevenson, K. E., Morrow, S. N., Scoyk, A. V., Blasco, R. B., Karaca, E., Meng, F., Frock, R. L., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801591115 · Cited by 13
Low dose ionizing radiation strongly stimulates insertional mutagenesis in a γH2AX dependent manner
Zelensky, A. N., Schoonakker, M., Brandsma, I., Tijsterman, M., van Gent, D. C., Essers, J., & Kanaar, R. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008550 · Cited by 15
Chen, H.-M., Resendes, R., Ghodssi, A., Sookiasian, D., Tian, M., Dollive, S., Adamson-Small, L. A., Avila, N., Tazearslan, C., Thompson, J. F., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233373 · Cited by 14
Petri, K., Gabriel, R., Agúndez, L., Fronza, R., Afzal, S., Kaeppel, C., Linden, R. M., Henckaerts, E., & Schmidt, M. (2015) · Journal of Virology · doi:10.1128/jvi.00426-15 · Cited by 12
Chakraborty, S. (2019) · F1000Research · doi:10.12688/f1000research.20744.1 · Cited by 14
Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders
Ghasemzad, M., Hashemi, M., Miri-Lavasani, Z., Hossein‐Khannazer, N., Bakhshandeh, H., Gramignoli, R., Alikhani, H. K., Najimi, M., Nikeghbalian, S., & Vosough, M. (2022) · Bioengineering · doi:10.3390/bioengineering9080392 · Cited by 12
Improved Genome Editing through Inhibition of FANCM and Members of the BTR Dissolvase Complex
de Alencastro, G., Puzzo, F., Pavel-Dinu, M., Zhang, F., Pillay, S., Majzoub, K., Tiffany, M. R., Jang, H., Sheikali, A., Cromer, M. K., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.10.020 · Cited by 13
Bunnell, B. A., Izadpanah, R., Ledebur, H. C., & Perez, C. F. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.2.195 · Cited by 11
Sonogenetics in the Treatment of Chronic Diseases: A New Method for Cell Regulation
Zhu, M., Fang, Y., Sun, Y.-K., Li, S., Yu, J., Xiong, B., Wen, C., Zhou, B., Huang, B., Yin, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202407373 · Cited by 14
Phoenix rising: gene therapy makes a comeback
Limberis, M. P. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms036 · Cited by 14
Janovitz, T., Sadelain, M., & Falck-Pedersen, E. (2014) · Virology Journal · doi:10.1186/1743-422x-11-15 · Cited by 12
Khanahmad, H., Mirian, M., Pirposhteh, R. T., Salehi, M., Jahanian‐Najafabadi, A., Sadeghi‐Aliabadi, H., & Kouhpayeh, S. (2016) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.192485 · Cited by 10
Marschhofer, M., Chen, S., Molbay, M., Winkeljann, B., Villano, E., Giancaspro, C., Kourou, A., Berninghausen, O., Rieder, S., Ungewickell, C., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114607 · Cited by 15
Basic and Clinical Application of Adeno-Associated Virus–Mediated Genome Editing
He, X., Xie, H., Liu, X., & Gu, F. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.190 · Cited by 7
Miller, D. G. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-370-7_13 · Cited by 10
Self-citationAdachi, K., & Nakai, H. (2011) · InTech eBooks · doi:10.5772/24265 · Cited by 9
Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight
Zhang, Z., Zhang, S., Wong, H. T., Li, D., & Feng, B. (2024) · BioDrugs · doi:10.1007/s40259-024-00654-5 · Cited by 11
Wallace, K. A., Gerstenberg, T. L., Ennis, C. L., Pérez-Bermejo, J. A., Partridge, J. R., Bandoro, C., Matern, W. M., Andreoletti, G., Krassovsky, K., Kabir, S., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.036 · Cited by 8
Moço, P. D., Farnós, O., Sharon, D. M., & Kamen, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100486 · Cited by 9
Siow, K. M., Güngör, M., Wrona, D., Raimondi, F., Pastukhov, O., Tsapogas, P., Menzi, T., Schmitz, M., Kulcsár, P. I., Schwank, G., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102229 · Cited by 8
Klapwijk, J. C., Río-Espínola, A. D., Libertini, S., Collin, P., Fellows, M. D., Jobling, S., Lynch, A. M., Martus, H., Vickers, C. A., Zeller, A., et al. (2024) · Human Gene Therapy · doi:10.1089/hum.2024.033 · Cited by 9
Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci
Calabria, A., Cipriani, C., Spinozzi, G., Rudilosso, L., Esposito, S., Benedicenti, F., Albertini, A., Pouzolles, M., Luoni, M., Giannelli, S. G., et al. (2023) · Blood · doi:10.1182/blood.2022017378 · Cited by 23
Shirk, P. D., & Furlong, R. B. (2016) · Plasmid · doi:10.1016/j.plasmid.2016.01.001 · Cited by 8
Silent IL2RG Gene Editing in Human Pluripotent Stem Cells
Li, L. B., Ma, C., Awong, G., Kennedy, M., Gornalusse, G. G., Keller, G. M., Kaufman, D. S., & Russell, D. W. (2015) · Molecular Therapy · doi:10.1038/mt.2015.190 · Cited by 7
Self-citationAAVS1-Targeted Plasmid Integration in AAV Producer Cell Lines
Luo, Y., Frederick, A., Martin, J. M., Scaria, A., Cheng, S. H., Armentano, D., Wadsworth, S. C., & Vincent, K. A. (2017) · Human Gene Therapy Methods · doi:10.1089/hgtb.2016.158 · Cited by 7
Mohanty, S. K., Batabyal, S., Ayyagari, A. L., & Sharif, N. A. (2024) · The Journal of Gene Medicine · doi:10.1002/jgm.3720 · Cited by 6
Applying horizontal gene transfer phenomena to enhance non-viral gene therapy
Elmer, J. J., Christensen, M. D., & Rege, K. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.025 · Cited by 9
Suzuki, K., Ohbayashi, F., Nikaido, I., Okuda, A., Takaki, H., Okazaki, Y., & Mitani, K. (2010) · Chromosome Research · doi:10.1007/s10577-010-9111-5 · Cited by 6
Effect of poly(ADP‐ribose) polymerase 1 on integration of the adeno‐associated viral vector genome
Romanova, L. G., Zacharias, J., Cannon, M. L., & Philpott, N. J. (2011) · The Journal of Gene Medicine · doi:10.1002/jgm.1577 · Cited by 9
Katona, R. L., Vanderbyl, S. L., & Perez, C. F. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-099-7_14 · Cited by 6
AAV-mediated genome editing is influenced by the formation of R-loops
Puzzo, F., Crossley, M. P., Goswami, A., Zhang, F., Pekrun, K., Garzon, J. L., Cimprich, K. A., & Kay, M. A. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.09.035 · Cited by 4
Transforming Hemophilia Management: Lessons from Gene Therapy Clinical Trials
Hussain, M. S., Maqbool, M., Arab, M. M., Rana, A. J., Ashique, S., Khan, Y., Jakhmola, V., & Gupta, G. (2025) · Molecular Biotechnology · doi:10.1007/s12033-025-01464-y · Cited by 6
Metadata
- Authors
- Miller, D. G., Petek, L. M., & Russell, D. W.
- Affiliations
- University of Washington (US)
- Corresponding author
- Russell, David W
- ORCID
- Miller, Daniel G
- Venue
- Nature Genetics
- Published
- 2004-06-20
- Volume
- 36
- Issue
- 7
- Pages
- 767-773
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2050289194
- Cited by
- 266
- References
- 30
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 16 · 2023: 21 · 2022: 12 · 2021: 11 · 2020: 22 · 2019: 11 · 2018: 6 · 2017: 4 · 2016: 11 · 2015: 18 · 2014: 9 · 2013: 7 · 2012: 11
- FWCI
- 7.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK062100)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adeno-associated virus vectors, viral integration, chromosome breakage, DNA double-strand breaks, I-SceI endonuclease, microhomology, etoposide, gamma irradiation, provirus, mutation rate, gene therapy vectors
- MeSH terms
- Dependovirus, Base Sequence, DNA, Genetic Vectors, Humans, Molecular Sequence Data, Plasmids, Chromosome Fragile Sites, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.